Home » Stocks » SMTI

Sanara MedTech, Inc. (SMTI)

Stock Price: $33.93 USD 5.94 (21.22%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 213.55M
Revenue (ttm) 14.15M
Net Income (ttm) -5.57M
Shares Out 6.29M
EPS (ttm) -1.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $33.93
Previous Close $27.99
Change ($) 5.94
Change (%) 21.22%
Day's Open 33.93
Day's Range 28.60 - 33.93
Day's Volume 3,509
52-Week Range 28.17 - 35.01

More Stats

Market Cap 213.55M
Enterprise Value 212.53M
Earnings Date (est) Jan 1, 1970
Ex-Dividend Date n/a
Shares Outstanding 6.29M
Float n/a
EPS (basic) -1.29
EPS (diluted) -1.06
FCF / Share -0.70
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5,354
Short Ratio 0.83
Short % of Float n/a
Beta 2.34
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 15.09
PB Ratio 36.48
Revenue 14.15M
Operating Income -5.65M
Net Income -5.57M
Free Cash Flow -4.35M
Net Cash 1.03M
Net Cash / Share 0.16
Gross Margin 74.61%
Operating Margin -39.89%
Profit Margin -39.40%
FCF Margin -30.74%
ROA -50.53%
ROE -311.36%
ROIC -292.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth101.56%-7.41%14.47%63.33%28.09%52.49%47.11%-46.89%142.71%-
Gross Profit10.565.335.504.562.481.830.930.381.410.37
Operating Income-2.74-0.500.12-0.27-0.96-2.06-2.93-5.42-5.01-2.48
Net Income-2.81-0.600.33-0.42-1.34-2.28-4.15-1.85-12.74-6.64
Shares Outstanding2.
Earnings Per Share-1.32---1.00-2.00-3.00-5.00-3.00-23.00-19.00
Operating Cash Flow-2.170.28-0.140.41-1.20-1.69-1.82-1.23-0.34-1.49
Capital Expenditures-0.18-0.01-0.04--0.01-0.01-0.03---
Free Cash Flow-2.350.27-0.180.41-1.21-1.69-1.85-1.23-0.34-1.49
Cash & Equivalents6.610.180.460.830.180.520.040.050.960.06
Total Debt2.10-1.201.621.821.611.702.421.372.58
Net Cash / Debt4.510.18-0.74-0.78-1.64-1.08-1.66-2.37-0.40-2.52
Book Value6.610.590.10-0.42-1.27-0.83-2.47-3.81-3.860.56
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Sanara MedTech, Inc.
Country United States
Employees 38
CEO J. Michael Carmena

Stock Information

Ticker Symbol SMTI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier NASDAQ: SMTI


Sanara MedTech develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder that helps in the natural wound healing process; Biako¯s Antimicrobial Skin & Wound Cleanser, a patented wound cleansing spray that disrupts extracellular polymeric substances to eradicate biofilm; and Biako¯s Antimicrobial Skin & Wound Irrigation Solution that works to irrigate and remove microbes from the wound bed to help eliminate planktonic, immature, and mature biofilms. It also provides Biako¯s Antimicrobial Wound Gel, a patented gel that synergistically disrupts extracellular polymeric substances to help eliminate biofilm microbes in the gel to help in wound healing; HYCOL Hydrolyzed Collagen, an additive free Type I bovine collagen that offers hydrolyzed collagen fragments to the wound bed that are a fraction of the size of native collagen; and PULSAR II Advanced Wound Irrigation Debridement System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.